Replies to post #4296 on Axim Biotechnologies Inc (AXIM)

[Blue Skys]

Some good news is that it was posted that Dr. Douglas Lake had left because there was a new Chief Science Officer. He has a title in the Sapphire business unit now and is apparently as engaged as ever. Its interesting that the Sapphire name is still on the AXIM front door. I think that will save them a few dollars when the final restructuring is completed down the road.

[TexasMarvL]

I will say this about the MJNA ownership connection. Granted, I didn't like the MJNA connection a few years ago.

However I have learned to understand things differently now. In fact, one could argue that AXIM might not have survived without MJNA ownership.

As far as the share dilution over the last few years, we'll that is part of the start-up business model. Start-ups sell shares when they don't have a product to sell.

Now AXIM has a couple of products to sell and another one hopefully in 2024.
As shareholders the current share price has hopefully provided everyone with the opportunity to add cheap shares along with management, MJNA, and Verséa.

My guess is eye doctors will start buying shares soon.